Health Condition 1: C00-D49- Neoplasms
Conditions
Interventions
Intervention1: Potentised form of Cisplatin (1C): Potentised chemotherepay agent
Intervention2: Potentised form of Docetaxel (1C): Potentised chemotherepay agent
Sponsors
Central Council for Research in Homoeopathy
Eligibility
Inclusion criteria
Inclusion criteria: 1 Pre-diagnosed cases of cancer advised to undergo/undergoing chemotherapy with either cisplatin and/or Docetaxel. 2 Any age group 18 years or above; willing to give written informed consent for participation.
Exclusion criteria
Exclusion criteria: Patients having chemotherapy with drugs other than cisplatin and docetaxel.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in CTCAE grading and Naranjo ADR score of various components of ADR, every two weeks, physically or telephonically, or as the case may be depending on the next chemotherapy session.Timepoint: Decline in CTCAE grading and Naranjo ADR score of various components of ADR, every two weeks, physically or telephonically, or as the case may be depending on the next chemotherapy session. | — |
Secondary
| Measure | Time frame |
|---|---|
| Adherence to chemotherapy regimen, as prescribed by consulting oncologist for at least six months, or for the entire duration of chemotherapy as planned, whichever is earlier.Timepoint: Completion of chemotherapy regimen, as prescribed by consulting oncologist for at least six months, or for the entire duration of chemotherapy as planned, whichever is earlier. | — |
Countries
India
Contacts
Public ContactDr Harleen Kaur
Apollo Hospitals, Chennai
Outcome results
None listed